205. SERDs Explained: What’s New in Breast Cancer Treatment with Dr. Sara Nunnery
On this episode of the Interlude Podcast, I am joined by breast medical oncologist, Dr. Sara Nunnery, to break down one of the most exciting and rapidly evolving areas of breast cancer treatment: selective estrogen receptor degraders (SERDs). We discuss how SERDs work, why ESR1 mutations matter, and how newer endocrine therapies are changing the…
204. Laurie Hutcheson, Executive Director of Lobular Breast Cancer Alliance
October 15th is Lobular Breast Cancer Awareness Day and today we are talking about lobular breast cancer! In this episode of the Interlude Podcast, I’m joined by Laurie Hutcheson, Invasive Lobular Cancer Patient Advocate & Executive Director of Lobular Breast Cancer Alliance (LBCA). Laurie and her team at LBCA are driving a bus across the…
203. All About Gynecologic Cancer with Gynecologic Oncologist, Dr. Melissa Hodeib
In this episode of the Interlude Podcast, I’m joined by board-certified gynecologic oncologist, Dr. Melissa Hodeib, to talk all about gynecologic cancer. September is Gynecologic Cancer Awareness Month and in this conversation, we discuss how to recognize, screen for, and reduce risk from gynecologic cancers while emphasizing patient advocacy and individualized care. In this conversation,…